Pharma/Biopharma

Human cells make new copies of their DNA billions of times each day, a crucial process upon which life itself depends. However, scientists do not fully understand how cells unzip the double-stranded DNA molecule before replicating both halves of it. New work at Rockefeller may help change that.

Possible pathway to adjustable filters, surfaces with variable mechanical response, or even new ways to deliver genes for biomedical applications.

Scientists at Thermo Fisher Scientific and BioAnalytix, Inc., of Cambridge, MA, are combining their expertise to develop advanced analytical profiling platforms and applications to characterize biologic and biosimilar drugs.

John Wiley & Sons, Inc., a global provider of knowledge and knowledge-enabled solutions that improve outcomes in research, professional practice, and education, announced today that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process. Terms were not disclosed.

Neuroscience and cancer research added to statewide priorities: about $61 million awarded to URI since program began in 2001. Brown University, Rhode Island College, Providence College, Bryant University, Roger Williams University, Salve Regina University and CCRI are partners in RI-INBRE program.













